glycyrrhiz
acid
main
activ
compon
licoric
root
known
tradit
chines
japanes
medicin
sinc
ancient
time
cultur
glycyrrhiz
acid
ga
one
frequent
use
drug
howev
centuri
novel
unusu
properti
ga
enhanc
activ
drug
discov
review
describ
briefli
experiment
evid
wide
spectrum
biolog
activ
glycyrrhiz
acid
well
discuss
possibl
mechan
abil
ga
enhanc
activ
drug
shown
due
amphiphil
natur
ga
abl
form
selfassoci
aqueou
nonaqu
media
well
water
solubl
complex
wide
rang
lipophil
drug
main
purpos
review
focu
reader
attent
physicochem
studi
molecular
mechan
ga
activ
drug
deliveri
system
dd
opinion
intrigu
featur
glycyrrhiz
acid
might
key
factor
therapeut
activ
abil
ga
incorpor
lipid
bilay
increas
membran
fluiditi
permeabl
abil
biomolecul
aggreg
chang
properti
cell
membran
great
signific
fundament
practic
point
view
monstrat
abil
ga
interact
cell
membran
http
doi
recent
advanc
nanotechnolog
supramolecular
chemistri
significantli
expand
capabl
address
wide
rang
medic
problem
one
import
scientif
achiev
use
nanoscal
supramolecular
aggreg
increas
solubl
stabil
lipophil
drug
improv
target
deliveri
sourc
diseas
kumari
et
al
patel
chaudhari
note
number
scientif
paper
devot
develop
drug
deliveri
system
dd
well
amount
fund
work
exceed
develop
research
new
drug
one
purpos
studi
search
new
nontox
complex
abl
protect
guest
molecul
reduc
hydrophob
control
reactiv
improv
bioavail
therapeut
activ
drug
molecul
purpos
present
review
introduc
novel
unusu
ddsglycyrrhiz
acid
glycyrrhiz
acid
ga
glycyrrhizin
saponin
licoric
root
ga
amphiphil
molecul
hydrophil
part
repres
glucuron
acid
residu
hydrophob
part
glycyrrhet
acid
residu
fig
ga
long
histori
use
known
sinc
ancient
time
ancient
china
egypt
japan
shibata
licoric
wide
use
tradit
chines
japanes
medicin
past
year
biolog
therapeut
activ
ga
intens
investig
asia
europ
shibata
ming
yin
su
et
al
confirm
nontox
ming
yin
notic
ga
one
wide
studi
triterpen
compound
number
refer
pubm
sinc
fig
time
total
number
public
devot
studi
ga
googl
scholar
number
public
notic
work
devot
biolog
activ
ga
antivir
anticanc
etc
small
part
devot
possibl
applic
ga
drug
carrier
studi
contain
attempt
understand
explain
mechan
ga
action
dd
last
decad
addit
therapeut
activ
novel
unusu
properti
ga
discov
particular
abil
ga
form
inclus
complex
varieti
drug
demonstr
baltina
apanasenko
et
al
polyakov
et
al
tolstikova
et
al
polyakov
leshina
polyakov
et
al
complex
show
signific
advantag
known
dd
addit
dechang
membran
properti
selyutina
et
al
selyutina
et
al
selyutina
et
al
selyutina
et
al
selyutina
et
al
cell
membran
form
boundari
extracellular
environ
intracellular
space
provid
cell
integr
implement
barrier
function
thu
understand
influenc
drug
deliveri
system
function
properti
cell
permeabl
elast
lipid
mobil
cell
viabil
particular
interest
review
tri
collect
systemat
avail
data
ga
biolog
activ
molecul
vivo
vitro
drug
carrier
hope
stimul
discuss
mechan
ga
action
perspect
ga
applic
multifunct
drug
carrier
number
data
antivir
activ
glycyrrhizin
variou
virus
thu
shown
ga
concentr
mm
inhibit
replic
epsteinbarr
viru
human
herpesviru
type
viru
vitro
lin
ga
select
index
time
higher
antivir
drug
zidovudin
time
lower
popular
drug
acyclovir
also
work
establish
mechan
ga
action
associ
direct
inactiv
viru
presum
effect
ga
occur
stage
viru
penetr
shown
glycyrrhiz
acid
could
inhibit
replic
coronaviru
sar
vitro
hoever
et
al
recent
research
antivir
activ
ga
variou
deriv
carri
vero
cell
line
obtain
kidney
epithelium
taken
african
green
monkey
found
concentr
ga
inhibit
cytopath
effect
destruct
cell
viru
infect
cell
time
ga
concentr
cell
viabil
decreas
mm
shown
glycyrrhizin
concentr
vitro
inhibit
cell
destruct
three
studi
strain
japanes
enceph
viru
nakayama
h
badam
similar
result
obtain
licoric
extract
ammonium
salt
ga
minimum
concentr
inhibit
observ
prove
nontox
pig
kidney
ps
cell
line
human
cervic
cancer
hela
abil
ga
inhibit
replic
number
virus
also
establish
vaccinia
viru
herp
simplex
viru
type
newcastl
diseas
viru
polioviru
type
vesicular
stomat
viru
pompei
et
al
pompei
et
al
studi
perform
vitro
human
aneuploid
cell
line
found
addit
mm
ga
infect
cell
cultur
inhibit
growth
vaccinia
virus
first
type
newcastl
diseas
vesicular
stomat
cytopath
effect
time
protect
cell
cultur
viral
exposur
prove
effect
practic
differ
infect
cell
treat
ga
noninfect
cell
upon
microscop
observ
posttreat
h
infect
mm
ga
also
lead
suppress
viru
growth
stop
progress
cytopath
effect
effect
also
observ
ga
concentr
mm
mm
absent
concentr
mm
along
irrevers
activ
first
herp
simplex
viru
observ
treatment
infect
cell
mm
glycyrrhiz
acid
min
note
effect
observ
virus
investig
work
even
process
h
also
effect
ga
first
type
polioviru
despit
abund
studi
ga
activ
variou
unbound
dna
rna
virus
mechan
antivir
effect
remain
unclear
shown
effect
ga
herp
viru
associ
kaposi
sarcoma
relat
inhibit
synthesi
viral
rna
kang
lieberman
ga
effect
replic
variou
virus
found
number
work
kimoto
et
al
sekizawa
et
al
baba
shigeta
howev
fact
ga
antivir
activ
detect
relat
variou
weakli
interconnect
dna
rna
virus
suggest
ga
effect
associ
effect
synthesi
rna
establish
lin
ga
ad
h
infect
cell
antivir
action
observ
time
addit
ga
immedi
infect
wash
ga
h
antivir
effect
remain
irrevers
base
conclud
ga
select
block
penetr
viru
cell
sinc
process
take
place
approxim
first
h
infect
case
viru
reproductiverespiratori
syndrom
pig
shown
ga
action
relat
mainli
stage
viru
penetr
littl
effect
stage
absorpt
releas
viru
duan
et
al
addit
author
exclud
direct
inhibitori
effect
ga
viral
particl
also
shown
number
studi
ga
deriv
prevent
penetr
number
virus
plasma
membran
lin
hoever
et
al
harada
cranc
et
al
sui
et
al
addit
found
effect
ga
lead
decreas
fluiditi
cell
membran
harada
wolkerstorf
et
al
also
establish
matsumoto
et
al
ga
prevent
spread
viru
inhibit
releas
viral
particl
infect
cell
summar
result
studi
conclud
key
featur
ga
respons
antivir
activ
might
membran
modifi
abil
question
discuss
long
time
glycyrrhizin
known
compound
antiinflammatori
activ
lot
studi
devot
issu
consid
antiinflammatori
activ
ga
mainli
term
inhibit
main
mediat
inflamm
interleukin
shown
glycyrrhizin
inhibit
product
vitro
matsumoto
et
al
number
studi
associ
ga
antiinflammatori
activ
antioxid
activ
particular
shown
along
compon
licoric
extract
glycyrrhizin
inhibit
synthesi
inflammatori
cytokin
model
lipopolysaccharidestimul
microgli
cell
fu
et
al
yu
et
al
also
ga
like
number
terpen
acid
demonstr
antioxid
activ
h
cell
human
bronchial
epithelium
tsao
yin
protect
mechan
ga
caus
fact
h
reduc
express
regul
apoptosi
ga
alreadi
revers
effect
concentr
experi
show
ga
decreas
viabil
cell
matsumoto
et
al
tsao
yin
treatment
h
decreas
viabil
increas
dna
fragment
test
cell
tsao
yin
pretreat
glycyrrhiz
acid
case
increas
viabil
cell
reduc
fragment
dna
addit
glycyrrhizin
reduc
product
oxid
inflamm
factor
induc
h
tsao
yin
akamatsu
et
al
demonstr
tsao
yin
akamatsu
et
al
ga
significantli
reduc
product
reactiv
oxygen
speci
particular
h
oh
radic
vitro
inhibit
neutrophil
metabol
particular
also
associ
antiinflammatori
effect
ga
anoth
put
mechan
ga
antiinflammatori
activ
associ
inhibit
synthesi
prostaglandin
one
inflamm
mediat
ohuchi
et
al
studi
macrophag
incub
h
medium
contain
differ
ga
concentr
signific
inhibit
synthesi
prostaglandin
activ
macrophag
observ
concentr
mgml
also
establish
ga
concentr
toxic
macrophag
one
suggest
mechan
ga
action
case
antivir
activ
chang
function
properti
plasma
membran
cell
treat
glycyrrhizin
particular
antivir
action
could
associ
degrad
lipid
raft
ga
extract
cholesterol
make
difficult
translat
receptor
lipid
raft
inhibit
lipopolysaccharideinduc
inflammatori
respons
cell
membran
protein
belong
group
tolllik
receptor
involv
congenit
immun
main
receptor
lipopolysaccharid
cell
therefor
directli
regul
cellular
respons
bacteri
lipopolysaccharid
marker
infect
matsumoto
et
al
number
experiment
data
indic
ga
specif
liver
diseas
particular
establish
glycyrrhizin
demonstr
hepatoprotect
effect
hepatoprotect
effect
number
toxic
compound
larg
determin
antioxid
activ
glycyrrhiz
acid
thu
shown
glycyrrhizin
significantli
reduc
necrosi
apoptosi
liver
cell
rat
expos
titanium
dioxid
nanoparticl
orazizadehet
al
also
studi
establish
ga
decreas
lipid
peroxid
demonstr
antioxid
activ
suggest
decreas
oxid
stress
significantli
caus
decreas
apoptosi
necrosi
hepatocyt
induc
titanium
dioxid
hepatoprotect
antioxid
properti
glycyrrhizin
also
manifest
relat
ccl
huo
et
al
yin
et
al
liang
et
al
number
cytotox
compound
wan
et
al
yin
et
al
li
et
al
wang
et
al
hsiang
et
al
studi
suggest
hepatoprotect
function
ga
includ
activ
liver
cancer
level
gene
express
yin
et
al
liang
et
al
particular
shown
ga
regul
express
gene
respons
apoptosi
oxid
stress
human
hepatoma
cell
wang
et
al
ga
antiinflammatori
antiapoptot
effect
treatment
liver
diseas
associ
suppress
tumor
necrosi
factor
caus
ga
hepatoprotect
effect
eltahawi
et
al
along
data
indic
manifest
hepatoprotect
function
ga
direct
exposur
liver
cell
particular
nakamura
et
al
induc
leakag
lactat
dehydrogenas
glutam
oxaloacet
transaminas
monolay
rat
hepatocyt
cultur
treat
cell
ccl
leakag
enzym
caus
chang
permeabl
membran
addit
glycyrrhizin
caus
chang
releas
enzym
small
chang
observ
glycyrrhizin
concentr
maximum
effect
observ
glycyrrhizin
ga
hepatoprotect
effect
could
connect
prevent
chang
permeabl
membran
hepatocyt
nakamura
et
al
number
studi
shown
glycyrrhiz
acid
demonstr
signific
anticanc
activ
abl
induc
apoptosi
tumor
cell
variou
cancer
type
cancer
hibasami
et
al
thirugnanam
et
al
exampl
daili
intraperiton
administr
mg
ga
per
kg
weight
mice
tumor
could
reduc
growth
cancer
cell
lead
bodi
weight
loss
drug
combin
includ
ga
also
studi
viabil
cell
human
chronic
myeloid
leukemia
reduc
ga
treatment
concentr
higher
mm
combin
ga
antileukem
drug
imatinib
ratio
mm
ga
per
imatinib
result
two
fold
increas
dna
fragment
cell
cultur
compar
caus
mm
ga
imatinib
alon
hostetl
et
al
studi
ga
influenc
apoptosi
leukemia
cell
mous
leukemia
cell
show
morpholog
chang
cell
dosedepend
charact
dna
damag
fragment
observ
cell
h
treatment
treat
cell
also
higher
yield
reactiv
oxygen
speci
apoptot
associ
protein
level
chueh
et
al
found
addit
glycyrrhet
also
known
glycyrrhitin
acid
metabolit
glycyrrhiz
acid
form
oral
use
fig
rat
liver
mitochondria
lead
loss
membran
potenti
swell
mitochondria
releas
cytochrom
c
result
indic
glycyrrhet
acid
capabl
initi
open
mitochondri
pore
thu
trigger
proapoptot
pathway
salvi
et
al
studi
shown
effect
result
combin
effect
glycyrrhet
acid
ca
gener
hydrogen
peroxid
interact
mitochondri
respiratori
chain
oxid
certain
thiol
group
endogen
pyridin
nucleotid
lead
open
mitochondri
pore
fior
et
al
mechan
also
manifest
siha
cell
deriv
cervic
cancer
materi
treat
glycyrrhet
acid
lee
et
al
mechan
interest
sinc
format
mitochondri
pore
involv
variou
form
cell
damag
well
apoptosi
open
mitochondri
pore
caus
depolar
transmembran
potenti
releas
ca
cytochrom
c
loss
cancer
cell
viabil
mignott
one
import
problem
medic
chemistri
moment
low
bioavail
use
medicin
compound
low
bioavail
mainli
determin
low
solubl
low
permeabl
solubl
drug
intend
oral
administr
especi
import
possibl
way
solv
problem
use
deliveri
system
form
complex
highli
solubl
compound
mani
case
allow
significantli
reduc
effect
dose
preserv
therapeut
effect
lipophil
drug
molecul
could
pass
lipid
layer
due
passiv
transport
concentr
gradient
necessari
achiev
suffici
larg
concentr
drug
compound
extracellular
environ
howev
releas
drug
compound
water
insolubl
take
account
near
popular
drug
taken
oral
could
say
trend
promis
number
physicochem
studi
show
complex
hydrophob
drug
glycyrrhiz
acid
capabl
increas
solubl
drug
factor
ten
time
compar
start
compound
variou
physicochem
method
appli
get
evid
complex
format
ga
selfassoci
drug
molecul
solid
state
well
aqueou
nonaqu
solut
complex
investig
fouriertransform
infrar
spectroscopi
differenti
scan
calorimetri
xray
diffract
scan
electron
microscopi
techniqu
lekar
et
al
yang
et
al
zu
et
al
kong
et
al
physicochem
properti
behavior
ga
complex
solut
character
nmr
mass
spectroscopi
electrochem
optic
techniqu
baltina
apanasenko
et
al
konkina
et
al
polyakov
et
al
particular
chang
mobil
drug
compound
presenc
ga
studi
h
nmr
spectroscopi
prove
format
inclus
complex
polyakov
et
al
time
spinlattic
spinspin
nuclear
relax
respect
sensit
chang
mobil
molecul
dees
dartz
bocian
chan
format
inclus
complex
result
decreas
diffus
mobil
molecul
lead
decreas
observ
relax
time
correspond
proton
invers
proport
rotat
correl
time
result
depend
rotat
mobil
molecul
thu
data
could
indic
molecul
free
bound
state
case
rapid
exchang
bound
state
solut
nmr
signal
decay
relax
experi
mono
exponenti
case
slow
exchang
comparison
relax
time
kinet
decay
becom
biexponenti
preexponenti
factor
case
correspond
fraction
molecul
differ
rotat
mobil
free
bound
fig
complex
ga
differ
drug
studi
mass
spectroscopi
particular
glycyrrhizin
complex
chloramphenicol
antibiot
studi
electrospray
ioniz
mass
spectrometri
vetrova
et
al
evid
complex
format
obtain
detect
chang
absorb
infrar
spectrum
chloramphenicol
use
ultravioletvis
infrar
spectroscopi
studi
complex
format
ga
chloramphenicol
ratio
regist
neg
ion
mode
also
establish
ga
deriv
form
complex
guanin
adenin
lekar
et
al
lphenylalanin
lekar
et
al
differ
anim
studi
shown
complex
nootrop
tranquil
drug
phenibut
glycyrrhizin
show
effect
analog
effect
drug
dose
reduc
time
tolstikova
et
al
addit
complex
increas
memori
abil
anim
reduc
phenibut
side
effect
drowsi
allerg
reaction
time
toxic
decreas
time
amplitud
therapeut
index
increas
time
tolstikova
et
al
similar
action
detect
complex
glycyrrhizin
drug
exampl
nifedipin
complex
ga
manifest
antihypertens
therapeut
effect
tenfold
reduc
dose
nifedipin
tolstikova
et
al
polyakov
leshina
antiinflammatori
activ
ga
salbutamol
test
use
tumor
necrosi
factoralphainduc
nfkappab
transcript
activ
report
assay
ikappab
western
blot
elisa
establish
ga
concentr
increas
level
mrna
beta
ar
vivo
accumul
camp
vitro
result
show
ga
salbutamol
demonstr
synergist
antiasthmat
effect
complex
ga
atorvastatin
simvastatin
also
demonstr
higher
effect
comparison
pure
drug
kong
et
al
stakhneva
et
al
amount
reductas
protein
rat
decreas
h
treatment
ga
complex
atorvastatin
simvastatin
respect
activ
enzym
decreas
rat
treat
ga
complex
atorvastatin
stakhneva
et
al
optic
spectroscopi
use
studi
protect
properti
complex
solut
known
mani
drug
compound
character
low
stabil
solut
photosensit
suscept
oxid
free
radic
form
bodi
vivo
etc
complex
glycyrrhiz
acid
case
significantli
improv
stabil
drug
substanc
protect
undesir
effect
thu
effect
variou
complex
includ
ga
oxid
resist
carotenoid
molecul
lutein
zeaxanthin
investig
polyakov
et
al
zeaxanthin
lutein
import
protect
role
eye
retina
human
mammal
lack
carotenoid
lead
eye
damag
shortwavelength
visibl
light
reactiv
oxygen
speci
eventu
lead
agerel
macular
degener
result
irrevers
blind
zeaxanthin
lutein
produc
human
bodi
enter
bodi
food
due
low
solubl
water
instabl
molecul
practic
use
consumpt
limit
prepar
supramolecular
complex
carotenoid
ga
disodium
salt
natur
polysaccharid
arabinogalactan
could
minim
mention
drawback
open
prospect
use
complex
food
industri
drug
product
complex
format
zeaxanthin
lutein
investig
nmr
relax
surfac
plasmon
reson
optic
absorpt
techniqu
polyakov
et
al
author
shown
complex
polysaccharid
ga
increas
solubl
carotenoid
time
also
oxid
resist
carotenoid
reaction
ozon
peroxyl
radic
metal
ion
investig
found
resist
oxid
lutein
zeaxanthin
significantli
increas
complex
glycyrrhiz
acid
arabinogalactan
fig
import
featur
ga
abil
reduc
cholesterol
oxid
form
water
solubl
complex
cholesterol
oxid
product
gluschenko
et
al
might
import
factor
prevent
cholesterol
plaqu
format
blood
vessel
atherosclerosi
develop
format
inclus
complex
facilit
format
selfassoci
ga
molecul
solut
alreadi
discuss
glycyrrhiz
acid
amphiphil
molecul
process
selfassoci
ga
studi
variou
method
thu
kornievskaya
et
al
format
selfassoci
prove
nmr
techniqu
shown
micel
glycyrrhiz
acid
occur
watermethanol
solut
low
content
methanol
wherea
micel
form
alcohol
content
increas
process
micel
gell
ga
watermethanol
mixtur
methanol
also
studi
petrova
et
al
shown
micel
format
occur
hydrophob
interact
triterpen
part
glycyrrhizin
studi
ga
selfassoci
molecular
dynam
also
demonstr
format
aggreg
occur
due
hydrophob
interact
terpen
residu
zelikman
et
al
studi
ga
micel
use
smallangl
scatter
method
show
ga
form
rodshap
micel
radiu
nm
length
nm
concentr
mm
solvent
ph
matsuoka
et
al
mass
spectrometri
studi
demonstr
glycyrrhet
acid
aglycon
glycyrrhiz
acid
also
form
selfassoci
lekar
et
al
abil
selfassoci
aqueou
solut
complex
drug
make
ga
promis
agent
drug
deliveri
despit
ga
usual
use
target
unit
particular
liver
cell
current
studi
devot
use
ga
independ
dd
amorph
solid
dispers
sd
curcumin
cur
disodium
salt
glycyrrhiz
acid
na
ga
prepar
mechan
ball
mill
show
mark
improv
factor
oral
bioavail
rat
model
zhang
et
al
curcumin
load
micel
selfform
sd
dissolv
water
vitro
cytotox
test
demonstr
higher
cytotox
cur
load
ga
micel
glioblastoma
mg
cell
free
cur
besid
improv
membran
permeabl
cur
confirm
parallel
artifici
membran
permeabl
assay
pampa
employ
solid
dispers
curcumin
allow
use
lower
dose
maintain
efficaci
help
overcom
disadvantag
color
tast
smell
complex
simvastatin
na
ga
also
show
enhanc
solubl
bioavail
kong
et
al
simvastatin
inhibitor
hmgcoa
reductas
wide
use
control
hypercholesterolemia
prevent
cardiovascular
diseas
pharmacokinet
test
vivo
laboratori
anim
show
increas
drug
bioavail
introduct
complex
na
ga
possibl
use
glycyrrhiz
acid
micel
deliveri
palitaxel
cytotox
anticanc
drug
character
low
oral
bioavail
studi
yang
coauthor
yang
et
al
ga
micel
contain
palitaxel
obtain
studi
size
nm
size
pure
micel
nm
suggest
drug
locat
insid
micel
fig
influenc
complex
format
spinspin
relax
time
molecul
adopt
gluschenko
apanasenko
et
al
case
transmiss
electron
microscopi
imag
show
micel
spheric
solubl
palitaxel
compon
aggreg
ga
increas
function
ga
concentr
maximum
observ
increas
time
ga
concentr
mm
result
paclitaxelga
aggreg
demonstr
increas
oral
bioavail
approxim
compar
initi
compound
vivo
experi
presum
due
increas
absorpt
drug
intestin
prospect
use
ga
micel
transderm
deliveri
podophyllotoxin
pt
drug
treatment
human
papillomaviru
type
investig
wang
et
al
studi
show
solubl
podophyllotoxin
waterethanol
mixtur
increas
caiapproxim
fivefold
ratio
ptga
ethanol
size
pure
micel
condit
nm
micel
contain
drug
nm
micel
contain
pt
longer
releas
penetr
time
pt
solut
stabl
concentr
pt
skin
h
final
concentr
pt
skin
case
micel
higher
case
solut
effect
ga
chitosan
transderm
deliveri
carvediol
also
studi
sapra
et
al
found
solubl
carvediol
solut
contain
ga
increas
factor
compar
buffer
solut
permeabl
carvediol
skin
presenc
ga
also
significantli
higher
propylen
glycolethanol
mixtur
permeabl
carvediol
rat
epidermi
ga
solut
increas
compar
buffer
solut
vitro
experi
also
show
ga
concentr
higher
critic
concentr
micel
format
mm
impair
penetr
drug
epidermi
presumpt
mechan
enhanc
skin
permeabl
associ
modul
epiderm
barrier
state
action
biochem
composit
skin
use
scan
electron
microscopi
transmiss
electron
microscopi
also
reveal
use
ga
lead
format
small
pore
stratum
corneum
lot
studi
devot
use
ga
metabolit
glycyrrhet
acid
target
unit
liver
therapi
cai
et
al
wu
et
al
mention
ga
effect
hepatoprotect
agent
see
section
surfac
hepatocyt
rich
glycyrrhet
acid
receptor
open
prospect
use
glycyrrhiz
acid
target
deliveri
wu
et
al
demonstr
abil
use
ga
target
agent
human
serum
albumin
hsa
nanoparticl
load
resveratrol
resveratrol
natur
compound
demonstr
antiinflammatori
antimicrobi
possibl
anticanc
activ
due
low
solubl
use
limit
shown
hsa
nanoparticl
conjug
ga
increas
solubl
resveratrol
besid
drug
releas
persist
slow
fluoresc
spectroscopi
fitclabel
sampl
demonstr
uptak
hsaga
nanoparticl
load
resveratrol
cell
much
effect
uptak
nanoparticl
without
ga
ga
composit
anthelmint
drug
praziquantel
studi
term
bioavail
solubl
permeabl
variou
physicochem
techniqu
meteleva
et
al
signific
increas
praziquantel
permeabl
monolay
cell
composit
ga
observ
mean
parallel
artifici
membran
permeabl
assay
vivo
studi
mice
also
shown
increas
bioavail
factor
oral
administr
composit
meteleva
et
al
studi
indic
ga
also
glycyrrhet
acid
metabolit
ga
fig
use
target
drug
deliveri
liver
cell
chen
et
al
singh
et
al
particular
shown
glycyrrhet
acid
could
form
supramolecular
progel
curcumin
demonstr
enhanc
cellular
uptak
better
inhibit
cell
growth
cell
comparison
control
naphthylacet
acidcurcumin
hydrogel
glycyrrhet
acidcurcumin
hydrogel
could
consid
promis
materi
liver
tumor
chemotherapi
chen
et
al
fluoresc
microscop
studi
glycyrrhet
acid
conjug
coumarinbas
fluoroprob
demonstr
glycyrrhet
acid
select
uptaken
liver
cancer
cell
chang
liver
cancer
cell
also
prodrug
epirubicinglycyrrhet
acid
inact
form
epirubicin
activ
rich
esteras
activ
tumor
cell
microenviron
demonstr
better
select
liver
cancer
cell
free
epirubicin
singh
et
al
cai
coautor
review
differ
drug
deliveri
system
liposom
micel
nanoparticl
modifi
glycyrrhetin
acid
system
effect
glycyrretin
acid
target
agent
liver
cell
observ
addit
solubl
enhanc
lipophil
drug
complex
ga
number
studi
indic
drug
permeabl
enhanc
presenc
ga
provid
broad
prospect
appli
glycyrrhiz
acid
multifunct
dd
also
establish
ga
enhanc
absorpt
effect
varieti
drug
kong
et
al
sapra
et
al
radwant
aboulenein
chen
et
al
chakotiya
et
al
view
fact
movement
small
drug
molecul
gastrointestin
epithelium
regul
distens
constrict
tight
junction
observ
effect
could
connect
abil
glycyrrhizin
enhanc
penetr
molecul
cell
transport
drug
molecul
must
overcom
mani
barrier
form
monolay
multilay
membran
despit
cellular
structur
influenc
factor
way
drug
similar
differ
cell
number
result
indic
ga
may
enhanc
drug
penetr
cell
influenc
cell
membran
properti
selyutina
et
al
selyutina
et
al
selyutina
et
al
selyutina
et
al
selyutina
et
al
meteleva
et
al
particular
shown
ga
could
enhanc
permeabl
erythrocyt
cell
format
ion
selyutina
et
al
selyutina
et
al
selyutina
et
al
suggest
permeabl
enhanc
could
due
ga
membranemodifi
activ
confirm
hypothesi
interact
glycyrrhizin
palmitoyloleoylphosphatidylcholin
popc
liposom
dioleylphosphatidylcholin
dopc
dipalmitoylphosphatidylcholin
dppc
bilay
studi
nmr
molecular
dynam
md
techniqu
nmr
studi
show
joint
action
mm
cholesterol
mm
glycyrrhizin
lead
penetr
pr
ion
bilay
selyutina
et
al
also
presenc
glycyrrhizin
acceler
transport
format
ion
red
blood
cell
membran
compar
untreat
sampl
observ
selyutina
et
al
may
connect
ga
penetr
lipid
bilay
selyutina
et
al
ga
water
could
easili
connect
bilay
surfac
penetr
prefer
locat
outer
halflay
could
freeli
exchang
polar
part
halflay
hydrophob
interior
fig
penetr
could
carri
water
molecul
insid
bilay
could
explain
observ
acceler
small
molecul
transport
membran
selyutina
et
al
observ
effect
could
connect
ga
selfassoci
exampl
maximum
acceler
rate
formateion
exchang
erythrocyt
membran
notic
glycyrrhizin
concentr
near
critic
micelleform
concentr
selyutina
et
al
molecular
dynam
model
reveal
ga
could
penetr
bilay
differ
type
lipid
dppc
membran
rigid
one
three
type
studi
found
ga
could
penetr
inner
halflay
result
form
thin
could
lead
pore
format
make
bilay
permeabl
pr
ion
fig
sapra
et
al
demonstr
abil
ga
creat
small
pore
layer
surfac
intracellular
lipid
bilay
disord
rat
epidermi
vitro
may
involv
mechan
transderm
deliveri
carvedilol
also
observ
pore
format
carri
water
molecul
ga
may
contribut
passiv
transport
lipid
membran
molecul
supramolecular
complex
ga
dd
base
ga
may
increas
solubl
lowsolubl
drug
also
enhanc
penetr
cell
glycyrrhiz
acid
part
licoric
extract
approv
us
food
drug
administr
fda
exist
food
sweeten
omar
et
al
cosmet
ingredi
review
report
intraperiton
median
lethal
dose
glycyrrhetin
acid
metabolit
ga
fig
mice
mgkg
oral
mgkg
oral
rat
report
mgkg
higher
report
salt
also
studi
volunt
toxic
effect
observ
oral
administr
mgkgday
ga
week
cosmet
ingredi
review
european
union
propos
provision
figur
mgday
upper
limit
ingest
ga
limit
confirm
scientif
committe
food
omar
et
al
european
food
safeti
author
conclud
glycyrrhiz
acid
ammoni
safe
concentr
mgkg
complet
feed
speci
except
chicken
fatten
lay
hen
efsa
main
undesir
sideeffect
licoric
relat
mineralocorticoid
activ
glycyrrhet
acid
activ
metabolit
ga
inhibit
enzym
dehydrogenas
convert
cortisol
inact
cortison
inhibit
lead
disbal
cortisolcortison
convers
activ
mineralocorticoid
receptor
cortisol
result
state
appar
mineralocorticoid
excess
ame
olukoga
donaldson
omar
et
al
ame
includ
hypokalaem
alkalosi
water
sodium
retent
tendenc
hypertens
kaliuresi
suppress
reninangiotensinaldosteron
axi
shown
licoriceinduc
effect
activ
dehydrogenas
last
two
week
follow
cessat
intak
compound
period
urinari
glycyrrhet
acid
concentr
gradual
fall
olukoga
donaldson
develop
new
safe
effect
agent
drug
deliveri
gain
popular
nowaday
glycyrrhizin
main
activ
compon
licoric
root
show
extens
pharmacolog
activ
believ
great
futur
discuss
ga
show
pharmacolog
antivir
antiinflammatori
anticanc
hepatoprotect
etc
activ
well
enhanc
therapeut
effect
drug
molecul
one
explan
differ
type
ga
activ
whether
antivir
antiinflammatori
hepatoprotect
anticanc
ga
membranemodifi
activ
fig
demonstr
sever
exampl
illustr
chang
membran
permeabl
fluiditi
pore
format
chang
transmembran
potenti
ga
result
confirm
variou
physicochem
studi
gamembran
interact
lot
studi
also
shown
drug
solubl
increas
significantli
supramolecular
complex
ga
solubl
enhanc
facilit
passiv
transport
drug
molecul
cell
membran
supramolecular
complex
ga
permeabl
enhanc
also
could
caus
ga
incorpor
cell
membran
pore
format
lipid
membran
action
ga
result
addit
enhanc
solubl
stabil
drug
glycyrrhizin
could
also
affect
pharmacokinet
properti
combin
biolog
activ
featur
make
ga
perspect
multifunct
drug
deliveri
system
despit
varieti
avail
data
complex
ga
drug
littl
paper
devot
applic
ga
independ
drug
deliveri
system
paper
devot
use
modifi
agent
dd
increas
specif
liver
cell
take
account
varieti
drug
could
includ
supramolecular
complex
glycyrrhizin
observ
increas
cell
membran
permeabl
presenc
ga
also
ga
affin
liver
cell
conclud
ga
could
use
effect
rel
cheap
target
drug
deliveri
system
addit
glycyrrhiz
acid
consid
univers
nonselect
carrier
moment
number
vivo
studi
perform
prove
therapeut
potenti
ga
multifunct
dd
drug
low
solubl
low
permeabl
anim
studi
demonstr
signific
enhanc
bioavail
therapeut
activ
drug
composit
ga
develop
novel
multifunct
dd
could
influenc
properti
cell
membran
huge
import
fundament
practic
point
view
take
account
divers
import
function
biolog
membran
fig
possibl
mechan
ga
influenc
membran
permeabl
ga
incorpor
lipid
membran
make
thinner
adopt
selyutina
et
al
vital
activ
live
cell
studi
chang
properti
lipid
membran
variou
drug
biolog
activ
molecul
one
import
task
biophys
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
